Richard Drexel, MD
Interventional Cardiology · Coon Rapids, MNNPI 1760657589
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $16,808 of the $27,664 with a category attached, or 60.8%. 10 manufacturers reported payments, led by Medtronic at 40.5% of the total.
Across 150 payments — averaging $184.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$11K
- Edwards Lifesciences$5K
- Abbott$5K
- Cordis US CORP.$2K
- Boston Scientific$2K
- Ancora Heart, Inc.$2K
- plus $446 from 4 others
What the payments were for
- Consulting fees$3,73013%
- Travel & lodging$16,80861%
- Food & beverage$7,10526%
- Education$220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 38 | $11,210 |
| Edwards Lifesciences | 44 | $5,177 |
| Abbott | 43 | $4,654 |
| Cordis US CORP. | 1 | $2,200 |
| Boston Scientific | 9 | $2,140 |
| Ancora Heart, Inc. | 7 | $1,837 |
| Teleflex LLC | 2 | $320 |
| Abiomed | 2 | $70 |
| Inari Medical, Inc. | 3 | $38 |
| Opsens Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$10,020
- TRICLIP$2,283
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,786
- AccuCinch$1,765
- CROSSBOSS$1,022
- AVVIGO Guidance System$1,000
- Mitra Clip system$997
- SAPIEN 3 Ultra RESILIA$905
- MANTA$174
- PASCAL$169
- Telescope$158
- GUIDELINER$146
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$134
- COROFLOW$132
- CoreValve Evolut$131
How this compares
$27,664 in reported general payments places this provider in the 80th percentile of 84 interventional cardiology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 93 | $105,577 |
| XareltoRivaroxaban | 31 | $46,485 |
| EntrestoSacubitril/Valsartan | 12 | $16,759 |
| Rosuvastatin Calcium | 196 | $3,227 |
| Atorvastatin Calcium | 157 | $2,658 |
| Metoprolol Succinate | 187 | $2,494 |
| ClopidogrelClopidogrel Bisulfate | 155 | $2,158 |
| Prasugrel Hcl | 26 | $1,202 |
| Lisinopril | 81 | $974 |
| Losartan Potassium | 112 | $918 |
| Bumetanide | 18 | $811 |
| Metoprolol Tartrate | 66 | $719 |
| Carvedilol | 60 | $677 |
| Amlodipine Besylate | 79 | $659 |
| Warfarin Sodium | 41 | $552 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Coon Rapids
- Thom DahleSaint Cloud$1.1M
- Stephen KiddSaint Cloud$607K
- Brian StegmanSt Cloud$587K
- Emmanouil BrilakisMinneapolis$548K
- Wesley PedersenMinneapolis$493K
- Michael ManolesMinneapolis$201K
- Jay TraverseMinneapolis$198K
- Robert WilsonMinneapolis$176K
- Yale WangMinneapolis$168K
- Gregory HelmerEdina$126K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.